Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6292
Source ID: NCT02484209
Associated Drug: Metformin
Title: DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)
Acronym: DiaFrail
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: Metformin|DRUG: Glimepiride|DRUG: Metformin
Outcome Measures: Primary: Difference in hypoglycaemia occurrence (mild-moderate category) between treatment arms, The primary objective of this short PILOT study will be the evaluation of the difference (as % of variation of mild-moderate hypoglycaemic events) between the treatment arms, 16 weeks | Secondary: Duration of Hypoglycaemia, Duration in minutes with glucose less \<54 mg/dl (3 mmol/l) during a 24-h period, week 1|Duration of Hypoglycaemia, Duration in minutes with glucose less \<54 mg/dl (3 mmol/l) during a 24-h period, week 8|Duration of Hypoglycaemia, Duration in minutes with glucose less \<54 mg/dl (3 mmol/l) during a 24-h period, week 16
Sponsor/Collaborators: Sponsor: Diabetes Frail Ltd | Collaborators: Merck Sharp & Dohme LLC|University of Campania Luigi Vanvitelli
Gender: ALL
Age: OLDER_ADULT
Phases: PHASE3
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Start Date: 2016-02
Completion Date: 2016-11
Results First Posted:
Last Update Posted: 2017-07-28
Locations:
URL: https://clinicaltrials.gov/show/NCT02484209